- Conditions
- Celiac Disease
- Interventions
- Larazotide acetate, Placebo, Gluten 900 mg
- Drug · Dietary Supplement
- Lead sponsor
- 9 Meters Biopharma, Inc.
- Industry
- Eligibility
- 18 Years to 72 Years
- Enrollment
- 42 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2010
- U.S. locations
- 14
- States / cities
- Orange, California • Topeka, Kansas • Lexington, Kentucky + 11 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 55
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Lactose Intolerance
- Interventions
- Bifidobacterium adolescentis IVS-1 capsule, Placebo cellulose capsule
- Dietary Supplement · Other
- Lead sponsor
- Purdue University
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 35 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2024
- U.S. locations
- 1
- States / cities
- West Lafayette, Indiana
- Conditions
- Tolerance, Healthy Population
- Interventions
- Acute intake of one of the products (active comparator 1 to 9) or Placebo comparator
- Other
- Lead sponsor
- Mondelēz International, Inc.
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2022
- U.S. locations
- 1
- States / cities
- Addison, Illinois
- Conditions
- Irritable Bowel Syndrome (IBS)
- Interventions
- E. Coli Strain M17 Probiotic
- Dietary Supplement
- Lead sponsor
- Weill Medical College of Cornell University
- Other
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 35 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2006
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Colic, Gastrointestinal Tract Infections
- Interventions
- L. reuteri, Sunflower Oil
- Biological
- Lead sponsor
- The University of Texas Health Science Center, Houston
- Other
- Eligibility
- 18 Years to 60 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009 – 2011
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Food Selection
- Interventions
- White grape juice, Apple juice
- Other
- Lead sponsor
- University of Minnesota
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- Started 2015
- U.S. locations
- 1
- States / cities
- Saint Paul, Minnesota
- Conditions
- Premature Infant
- Interventions
- No gastric residual evaluation
- Other
- Lead sponsor
- University of Florida
- Other
- Eligibility
- Up to 3 Days
- Enrollment
- 61 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2013
- U.S. locations
- 1
- States / cities
- Gainesville, Florida
- Conditions
- Gastro-Intestinal Tolerance
- Interventions
- Control Infant Formula, Experimental Infant Formula, Reference Group
- Other
- Lead sponsor
- Abbott Nutrition
- Industry
- Eligibility
- Up to 14 Days
- Enrollment
- 189 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2020
- U.S. locations
- 19
- States / cities
- Tucson, Arizona • Sacramento, California • Norwich, Connecticut + 16 more
- Conditions
- Short Gut Syndrome
- Interventions
- Green bean puree
- Dietary Supplement
- Lead sponsor
- Children's Hospital of Philadelphia
- Other
- Eligibility
- 4 Months to 18 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2026
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Gastrointestinal Tolerance
- Interventions
- Infant Formula 1, Infant Formula 2
- Other
- Lead sponsor
- Abbott Nutrition
- Industry
- Eligibility
- 2 Weeks to 9 Weeks
- Enrollment
- 113 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 1996 – 1997
- U.S. locations
- 7
- States / cities
- Little Rock, Alaska • Aurora, Colorado • Stone Mountain, Georgia + 4 more
- Conditions
- Breast Cancer, Gastric Cancer, Gastroesophageal-junction Cancer
- Interventions
- IKS014
- Drug
- Lead sponsor
- Iksuda Therapeutics Ltd.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 165 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2027
- U.S. locations
- 4
- States / cities
- Newport Beach, California • Boston, Massachusetts • Nashville, Tennessee + 1 more
- Conditions
- Post Bariatricsurgery, Hypoglycemia
- Interventions
- Exendin-(9-39), Atropine, GLP-1 and GIP
- Drug
- Lead sponsor
- The University of Texas Health Science Center at San Antonio
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 160 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009 – 2027
- U.S. locations
- 2
- States / cities
- San Antonio, Texas
- Conditions
- Celiac Disease
- Interventions
- larazotide acetate
- Drug
- Lead sponsor
- 9 Meters Biopharma, Inc.
- Industry
- Eligibility
- 18 Years to 59 Years
- Enrollment
- 21 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2006
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Gastro-Intestinal Tolerance
- Interventions
- Study Oral Nutritional Supplement
- Other
- Lead sponsor
- Abbott Nutrition
- Industry
- Eligibility
- 3 Years to 10 Years
- Enrollment
- 25 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013
- U.S. locations
- 1
- States / cities
- Cincinnati, Ohio
- Conditions
- Gastrointestinal Tolerance
- Interventions
- Infant Formula supplemented with Oligosaccharides
- Other
- Lead sponsor
- Abbott Nutrition
- Industry
- Eligibility
- 7 Days to 42 Days
- Enrollment
- 69 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2016
- U.S. locations
- 13
- States / cities
- Birmingham, Alabama • Dothan, Alabama • Tucson, Arizona + 10 more
- Conditions
- Ulcerative Colitis
- Interventions
- Placebo, HE3286
- Drug
- Lead sponsor
- Harbor Therapeutics
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 27 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 10
- States / cities
- Tucson, Arizona • Anaheim, California • Fresno, California + 6 more
- Conditions
- Dairy Intolerance, Healthy Adults
- Interventions
- Conventional lactose-free cow's milk, Nonconventional (A2) cow's milk, Nonconventional (A2) lactose-free cow's milk
- Other
- Lead sponsor
- Auburn University
- Other
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 48 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024
- U.S. locations
- 1
- States / cities
- Auburn, Alabama
- Conditions
- Gastro-Intestinal Tolerance
- Interventions
- Study Infant Formula
- Other
- Lead sponsor
- Abbott Nutrition
- Industry
- Eligibility
- 7 Days to 65 Days
- Enrollment
- 18 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2022
- U.S. locations
- 14
- States / cities
- Dothan, Alabama • Spring Hill, Florida • Idaho Falls, Idaho + 9 more
- Conditions
- Gastrointestinal Tolerance of Probiotics in Infants
- Interventions
- Synbiotic Supplement, Lactose (inactive placebo)
- Dietary Supplement
- Lead sponsor
- Persephone Biosciences
- Industry
- Eligibility
- 2 Months to 24 Months
- Enrollment
- 200 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025
- U.S. locations
- 1
- States / cities
- San Diego, California
- Conditions
- Food Allergy, Eosinophilic Esophagitis
- Interventions
- Not listed
- Lead sponsor
- Children's Hospital of Philadelphia
- Other
- Eligibility
- 1 Month to 65 Years
- Enrollment
- 5,300 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2011 – 2030
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Cryptosporidiosis, HIV Infections
- Interventions
- Spiramycin
- Drug
- Lead sponsor
- Rhone-Poulenc Rorer
- Industry
- Eligibility
- 18 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- U.S. locations
- 1
- States / cities
- Horsham, Pennsylvania
- Conditions
- Celiac Disease
- Interventions
- larazotide acetate, Placebo
- Drug
- Lead sponsor
- 9 Meters Biopharma, Inc.
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 80 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2007
- U.S. locations
- 9
- States / cities
- Scottsdale, Arizona • San Diego, California • Boston, Massachusetts + 6 more
- Conditions
- Gastrointestinal Tolerance
- Interventions
- Inulin, soluble corn fiber
- Other
- Lead sponsor
- Tate & Lyle
- Industry
- Eligibility
- 3 Years to 9 Years
- Enrollment
- 44 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021
- U.S. locations
- 1
- States / cities
- Addison, Illinois
- Conditions
- Gastric Cancer
- Interventions
- S-1, cisplatin
- Drug
- Lead sponsor
- Taiho Oncology, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 41 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2006
- U.S. locations
- 11
- States / cities
- Los Angeles, California • Honolulu, Hawaii • Chicago, Illinois + 3 more